Haemophilus Influenzae Type Disease
📧 Sign up to get email alerts when something new happens for Haemophilus Influenzae Type Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-09-16Clinical Trial Update: Assess if Immune Response of GSK Biologicals' Tritanrix™-HepB/Hib-MenAC Given Without or With Hepatitis B Vaccine at Birth is at Least as Good as Tritanrix™-HepB/Hiberix™ Without Hepatitis B Vaccine at Birth, When Given to Healthy Infants [Phase 3]
This Phase 3 trial in healthy infants evaluated whether giving Tritanrix-HepB/Hib-MenAC with a birth-dose Hepatitis B vaccine yields an immu…
-
CLINICAL_TRIALS trial_result · 2016-08-05Clinical Trial Update: Immunogenicity and Reactogenicity of DTPa-HBV-IPV/Hib Vaccine Followed by the Same Vaccine and Oral Polio Vaccine [Phase 3]
Phase 3 trial update evaluating the immunogenicity and reactogenicity of the DTPa-HBV-IPV/Hib vaccine given in a schedule with subsequent va…
-
CLINICAL_TRIALS trial_result · 2016-01-05Clinical Trial Update: Antibody Persistence at Age 3.5 and 4.5 Years After Primary and Booster DTaP-IPV-Hep B-PRP~T or Infanrix Hexa Vaccination [Phase 3]
Phase 3 trial update reports antibody persistence at ages 3.5 and 4.5 years after primary and booster vaccination with DTaP-IPV-HepB-PRP~T o…
-
CLINICAL_TRIALS trial_result · 2015-12-16Clinical Trial Update: Study of Long-term Antibody Persistence After a Booster Dose of Menitorix Vaccine [Phase 4]
Long-term antibody persistence after a booster dose of Menitorix vaccine was studied in a Phase 4 trial; results were posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-05-21Clinical Trial Update: Follow-up Study on the Antibody Response to Hepatitis B, Acellular Pertussis Toxin and Inactivated Poliovirus Antigens 1 Month After the 4th Hexavac® Vaccination in Healthy Children, Who Participated in NeisVac-C Study 216
Follow-up study reports antibody responses to hepatitis B, acellular pertussis toxin, and inactivated poliovirus antigens 1 month after the …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-10-07Clinical Trial Update: Post-authorization Safety Study of Euforvac-Hib Vaccine for Active Primary Immunization in Infants From 6 Weeks
A post-authorization safety study evaluating the Euforvac-Hib vaccine for active primary immunization in infants starting at 6 weeks to moni…
-
CLINICAL_TRIALS trial_result · 2014-08-15Clinical Trial Update: Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine in Healthy Infants [Phase 2]
Phase 2 trial of GSK2202083A vaccine in healthy infants completed; multiple conditions tested including tetanus, hepatitis B, Hib, polio, ac…
-
CLINICAL_TRIALS trial_result · 2014-06-06Clinical Trial Update: Safety and Immunogenicity of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine (GSK217744) [Phase 2]
Phase 2 trial update on safety and immunogenicity of new formulations of GSK's DTPa-HBV-IPV/Hib vaccine (DTPa-HBV-IPV/Hib, GSK217744).
-
CLINICAL_TRIALS trial_result · 2014-05-02Clinical Trial Update: Comparison of DTaP-IPV-Hep B-PRP~T Combined Vaccine to CombAct-HIB® Concomitantly Given With Engerix B® Paediatric and OPV [Phase 3]
A Phase 3 trial comparing the DTaP-IPV-Hep B-PRP-T combined vaccine to CombAct-HIB given with Engerix B Paediatric and OPV; results were pos…
-
CLINICAL_TRIALS trial_result · 2014-04-01Clinical Trial Update: Comparison of a DTaP-IPV-HB-PRP~T Combined Vaccine to Infanrix™-Hexa, When Administered With Prevnar® in Thai Infants [Phase 3]
Phase 3 trial comparing DTaP-IPV-HB-PRP-T (Sanofi Pasteur) to Infanrix Hexa when co-administered with Prevnar in Thai infants; results were …
-
CLINICAL_TRIALS trial_result · 2013-12-30Clinical Trial Update: Comparison of GSKBiologicals' Hib-MenCY-TT Vaccine vs Licensed Hib Conjugate or Meningococcal Vaccine [Phase 2]
Phase 2 trial comparing Hib-MenCY-TT vaccine to licensed Hib conjugate or meningococcal vaccine; study completed with results posted in 2013…
-
CLINICAL_TRIALS trial_result · 2013-11-21Clinical Trial Update: Immunogenicity Study of Antibody Persistence and Booster Effect of DTaP-HB-PRP~T Combined Vaccine or Tritanrix-HepB/Hib™ [Phase 3]
Phase 3 immunogenicity study assessing antibody persistence and booster effects of the DTaP-HB-PRP~T combined vaccine (Tritanrix-HepB/Hib) d…
-
CLINICAL_TRIALS trial_result · 2013-11-14Clinical Trial Update: Immunogenicity Study of Antibody Persistence and Booster Effect of DTaP-HB PRP~T Combined Vaccine in Filipino Infants [Phase 3]
Phase 3 immunogenicity update evaluating antibody persistence and booster response of the DTaP-HB PRP-T combination vaccine in Filipino infa…
-
CLINICAL_TRIALS trial_result · 2012-08-06Clinical Trial Update: Safety and Immunogenicity Study of Hib-MenCY-TT Vaccine Compared to Licensed Hib Conjugate Vaccine [Phase 3]
Phase 3 trial comparing Hib-MenCY-TT vaccine to licensed Hib conjugate vaccine assessing safety and immunogenicity; completed with results p…
-
CLINICAL_TRIALS trial_result · 2012-07-23Clinical Trial Update: Dose Ranging Study of Combined Haemophilus Influenzae Type B-Meningococcal Serogroups CY (Hib-MenCY-TT) Vaccine [Phase 2]
Phase 2 dose-ranging study evaluating Hib-MenCY-TT vaccine; completed with results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-07-23Clinical Trial Update: 3 Formulations of Hib-MenCY-TT Vaccine & 1 Formulation of Hib-MenC-TT Vaccine Compared to Licensed Meningococcal Serogroup C Conjugate Vaccine, Each Administered at 2,3,4 Mths of Age [Phase 2]
A Phase 2 trial comparing multiple Hib-MenCY-TT and Hib-MenC-TT vaccine formulations to a licensed meningococcal vaccine in infants aged 2-4…
-
CLINICAL_TRIALS trial_result · 2012-07-20Clinical Trial Update: Safety of Hib-MenCY-TT Vaccine Versus Licensed Hib Conjugate Vaccine, Given at 12 to 15 Months of Age. [Phase 3]
Phase 3 trial comparing Hib-MenCY-TT vaccine to a licensed Haemophilus influenzae type b conjugate vaccine in children aged 12 to 15 months,…
-
CLINICAL_TRIALS trial_result · 2012-04-17Clinical Trial Update: Study of PENTAXIM™ Vaccine Versus TETRAXIM™ Vaccine Given With ACTHIB™ Vaccine in South Korean Infants. [Phase 3]
A Phase 3 study comparing PENTAXIM with TETRAXIM when co-administered with ACTHIB in South Korean infants has completed.
-
CLINICAL_TRIALS trial_result · 2010-12-23Clinical Trial Update: Persistence of Antibodies at 3, 4 and 6 Years of Age After Vaccination With Meningococcal, Pneumococcal and Hib Vaccines [Phase 3]
Phase 3 trial update reporting long-term antibody persistence after vaccination with meningococcal, pneumococcal, and Hib vaccines in childr…
-
CLINICAL_TRIALS trial_result · 2009-10-23Clinical Trial Update: Study in Toddlers to Demonstrate Non-inferiority of GSK Biologicals' Hib-MenC & to Evaluate Persistence up to 5 Years. [Phase 3]
Phase 3 clinical trial update assessing non-inferiority and 5-year persistence for GSK Hib-MenC in toddlers across Haemophilus influenzae ty…
-
CLINICAL_TRIALS trial_result · 2009-08-26Clinical Trial Update: Immunogenicity and Safety of GSK Biologicals' Infanrix/Hib in Children [Phase 3]
Phase 3 trial evaluating the immunogenicity and safety of GlaxoSmithKline's Infanrix/Hib vaccine in children; results were posted in 2009.
-
EMA withdrawal · 2008-09-10EMA Withdrawn: Quintanrix (Diphtheria toxoid;tetanus toxoid;inactivated Bordetella pertussis;hepatitis B surface antigen (rDNA);Haemophilus influenzae type b polysaccharide) — GlaxoSmithKline Biologicals S.A.
Quintanrix has been withdrawn from the market by GlaxoSmithKline Biologicals S.A., with the status indicating withdrawal for its diphtheria,…
-
CLINICAL_TRIALS trial_result · 2006-12-08Clinical Trial Update: Assess Immune Response Following Primary Vaccination With Tritanrix™-HepB Vaccine Mixed With 3 Formulations of Hib-MenAC Vaccine to Infants [Phase 2]
Phase 2 trial assessing immune response in infants after primary vaccination with Tritanrix-HepB mixed with three Hib-MenAC vaccine formulat…